APOTHEEK TILIA

Active

Private limited companyfounded 1992active for 33 yearsDrie Eikenstraat 655, 2650 Edegem, Belgium23 active companies are registered at this addressKBO/BCE: BE 0448.760.404

From the official registers: KBO 31 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

APOTHEEK TILIA has been active since 1992 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €677,219 and a net result of €168,999. Equity is growing by about 6.2% per year across the filed financial years. Its solvency ranks better than 79% of 12,737 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

APOTHEEK TILIAActiveChecked score 97/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 03-12-1992 Normal situation
Legal form: Private limited company
Registered office: Drie Eikenstraat 655, 2650 Edegem
Activity: Retail sale of pharmaceutical products NACE 47730
Establishment unit: 2.228.869.562 2650 Edegem, since 03-12-1992
Financial year end: 30 September
Peppol: Reachable since 20-11-2025

Company details

Who decides

Board

Guy HANSManaging director
Jens VAN KRIEKENManaging director
Sophie CooremanManaging director

Shareholders

Universitair Ziekenhuis Antwerpen IVZWannual accounts 30-09-2024

Board & ownership

How it is doing

97 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: < 0.1%

Annual accounts to 30-09-2025

Gross margin: €734,628; ▲ 22.5%
Turnover: ≈ €2.7m; estimated
Profit: €168,999; ▲ 36.3%
Equity: €677,219; ▲ 8.1%
Total assets: €1.0m; ▼ 2.2%
Staff: 6.1 FTE

2025 accounts 6 days early

Filed on 24-04-2026PDF

Financials

Why 97lowers riskLiquidity: current ratio 2.76, cash €370,843Founded in 1992Equity €677,219 (66.6% of total assets)Profit of €168,999 (financial year 2025)Show the evidence

Checked score

Score 2025

97 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 76% of its sector peers (NACE 47, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 92+7

equity 66.6% of total assets

Liquidity 81=

short-term debt 33.4% · cash 36.5%

Profitability 90+6

return on assets 16.6%

Bankruptcy probability, 12 months

< 0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,270 companies, NACE 47, micro)

Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: 0.1%▲ +0.1 percentage points vs 03-2025highest value 05-2025: < 0.1%▼ -0.1 percentage points vs 04-2025lowest value 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: 0.1%▲ +0.1 percentage points vs 03-2026 05-2026: < 0.1%▼ -0.1 percentage points vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026

Credit of up to €65,000 on 30-day terms is acceptable

Liquidity ample (current ratio 2.76, compared with 2.35 in 2024, above the usual 1.5; short-term debt: 33.4% and cash: 36.5% of total assets), and 33.4% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 78% on solvency, 85% on liquidity, 84% on profitability and 58% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskneutral

Liquidity: current ratio 2.76, cash €370,843

NBB · annual accounts

Founded in 1992

Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.

KBO

Equity €677,219 (66.6% of total assets)

NBB · annual accounts

Profit of €168,999 (financial year 2025)

NBB · annual accounts

Latest accounts filed on time

The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 24-04-2026, 6 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

6 days early

2024

8 days early

2023

on the day

2022

4 days early

2021

11 days early

2020

38 days early

2019

34 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 14 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 24 April (5 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

30-09-2026 year end01-11-2026 today30-04-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

Key points

Positive: Among the best 15% on net resultsector median €27,659 · 12,727 companies €168,999 View
Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
Board changedlatest change 02-02-2026 · 3 in office 1 joined · 1 left View
Positive: 5 profitable years in a rowprofit 2025: €168,999 5 years View

Documents

Key facts about APOTHEEK TILIA

What is the company number of APOTHEEK TILIA?: 0448.760.404. In Belgium the VAT number is the company number with BE in front: BE 0448.760.404.
Where is APOTHEEK TILIA based?: The registered office is at Drie Eikenstraat 655, 2650 Edegem.Company details
What does APOTHEEK TILIA do?: According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK TILIA?: Private limited company (BV).
When was APOTHEEK TILIA founded?: On 03-12-1992.
Is APOTHEEK TILIA still active?: Yes, APOTHEEK TILIA is an active enterprise in the KBO register.
How many employees does APOTHEEK TILIA have?: On average 6.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of APOTHEEK TILIA?: ≈ €2.7m in financial year 2025. Estimated from the gross margin of €734,628: probably between €2.1m and €4.4m, based on 47 comparable companies, NACE 477.
Is APOTHEEK TILIA profitable?: In financial year 2025, APOTHEEK TILIA made a profit of €168,999.
Where can I find the annual accounts of APOTHEEK TILIA?: APOTHEEK TILIA filed 31 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of APOTHEEK TILIA due?: By 30-04-2027, for financial year 2026.Timeline